Catalyst Pharmaceuticals, Inc.
$31.38
The Read: 4% on regulatory and June 25 outcomes, with a 16% surge outside the band driven by record Agamree sales and analyst upgrades, but showed minimal price change near its Angelini Pharma acquisition announcement.
Price
Overlays
Panel
CPRX
Hover to view data
No Data